Ning Deng
Impact in
- Genetics top 10%
- Mesenchymal stem cell research
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Fibroblast Growth Factor Research 5
- RNA Interference and Gene Delivery 3
- Glycosylation and Glycoproteins Research 2
-
- Cancer, Hypoxia, and Metabolism 4
- Co-authors
- Shoumei Bai (2 shared papers)Ronald J. Buckanovich (2 shared papers)Ligang Zhang (5 shared papers)Xi Chen (2 shared papers)Chunyan Liu (2 shared papers)Yusong Gong (1 shared paper)Evan T. Keller (1 shared paper)Karen McLean (1 shared paper)
- Journals
- Biochemical and Biophysical Research Communications (1 paper)Pharmaceutics (1 paper)The Journal of Biochemistry (1 paper)Engineering in Life Sciences (1 paper)IUBMB Life (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Ning Deng
17 papers receiving 688 citations
Peers
Comparison fields: 5 of 72
- Genetics 107
- Cancer Research 139
- Oncology 242
- Molecular Biology 398
- Biomaterials 70
Countries citing papers authored by Ning Deng
This map shows the geographic impact of Ning Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Deng more than expected).
Fields of papers citing papers by Ning Deng
This network shows the impact of papers produced by Ning Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Deng. The network helps show where Ning Deng may publish in the future.
Co-authors
The 25 scholars most cited alongside Ning Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 301 | |
| 2 | 2020 | 178 | |
| 3 | 2016 | 51 | |
| 4 | 2024 | 27 | |
| 5 | 2010 | 22 | |
| 6 | 2020 | 22 | |
| 7 | 2020 | 21 | |
| 8 | 2016 | 18 | |
| 9 | 2022 | 17 | |
| 10 | 2021 | 11 | |
| 11 | 2017 | 9 | |
| 12 | 2020 | 6 | |
| 13 | Molecular mechanism of reversal effect of monoclonal antibody to basic fibroblast growth factor-mediated expression of P-glycoprotein on multiple drug resistance in adriamycin-resistant human breast cancer cell line MCF-7/ADM | 2013 | 3 |
| 14 | 2018 | 3 | |
| 15 | 2023 | 2 | |
| 16 | Disabling the Nuclear Translocalization of RelA/NF-κB by a Small Molecule Inhibits Triple-Negative Breast Cancer Growth | 2021 | 1 |
| 17 | 2020 | 1 | |
| 18 | 2025 | 0 | |
| 19 | 2012 | 0 |
About Ning Deng
Ning Deng is a scholar working on Molecular Biology, Cancer Research, Oncology, Cell Biology and Biomaterials, having authored 19 papers that have together received 693 indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (5 papers), Proteoglycans and glycosaminoglycans research (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), RNA Interference and Gene Delivery (3 papers), Cancer Cells and Metastasis (3 papers), Glycosylation and Glycoproteins Research (2 papers), Nanoparticle-Based Drug Delivery (2 papers) and Platelet Disorders and Treatments (2 papers). The work is most often cited by research in Genetics (107 citations), Cancer Research (139 citations), Oncology (242 citations), Molecular Biology (398 citations) and Biomaterials (70 citations). Ning Deng has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Shoumei Bai, Ronald J. Buckanovich, Ligang Zhang, Xi Chen, Chunyan Liu, Yusong Gong, Evan T. Keller, Karen McLean, Kathleen R. Cho and Yun‐Jung Choi. Their work appears in journals such as Biochemical and Biophysical Research Communications, Pharmaceutics, The Journal of Biochemistry, Engineering in Life Sciences and IUBMB Life.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.